GTBPVSWRBY• 6 Months (Normalized)
GTBP vs WRBY (GT Biopharma Inc. vs Warby Parker Inc.)
Showing Closing Date Range from Apr 3 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.88
+1444.94%
GT Biopharma Inc.
Normalized Baseline0.00%
WRBY Performance $27.47
+30.5%
Warby Parker Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+1414.44 pts
GTBP outperforming by 1414.44 percentage points
GTBPWRBY
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP WRBY
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(122 dates)
| Date | GTBP Price | GTBP Gain (%) | WRBY Price | WRBY Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $6.88 | +1444.94% | $27.47 | +30.50% | +1414.44% |
| Sep 28, 2026 | $6.80 | +1428.09% | $24.66 | +17.15% | +1410.94% |
| Sep 25, 2026 | $6.89 | +1448.31% | $26.71 | +26.89% | +1421.42% |
| Sep 24, 2026 | $6.83 | +1434.83% | $26.27 | +24.80% | +1410.03% |
| Sep 23, 2026 | $7.10 | +1495.51% | $23.35 | +10.93% | +1484.58% |
| Sep 21, 2026 | $7.18 | +1513.48% | $23.25 | +10.45% | +1503.03% |
| Sep 18, 2026 | $7.16 | +1508.99% | $22.50 | +6.89% | +1502.10% |
| Sep 17, 2026 | $7.49 | +1583.15% | $24.18 | +14.87% | +1568.28% |
| Sep 16, 2026 | $7.81 | +1655.06% | $23.55 | +11.88% | +1643.18% |
| Sep 15, 2026 | $9.00 | +1922.47% | $24.34 | +15.63% | +1906.84% |
| Sep 14, 2026 | $11.63 | +2513.48% | $25.71 | +22.14% | +2491.34% |
| Sep 11, 2026 | $8.61 | +1834.83% | $24.71 | +17.39% | +1817.44% |
| Sep 10, 2026 | $6.18 | +1288.76% | $24.30 | +15.44% | +1273.32% |
| Sep 09, 2026 | $5.98 | +1243.82% | $24.57 | +16.72% | +1227.10% |
| Sep 08, 2026 | $- | $24.76 | +17.62% | - |
Page 1 of 9